Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor

被引:241
作者
AbuAmer, Y [1 ]
Ross, FP [1 ]
Edwards, J [1 ]
Teitelbaum, SL [1 ]
机构
[1] WASHINGTON UNIV, SCH MED, DEPT PATHOL, BARNES JEWISH HOSP N, ST LOUIS, MO 63110 USA
关键词
bone resorption; periodontitis; tumor necrosis factor receptor; thalidomide; bone marrow macrophages;
D O I
10.1172/JCI119679
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Chronic bone infection, as attends periodontitis, is often complicated by severe osteolysis. While LPS is believed to be central to the pathogenesis of the osteolytic lesion, the mechanisms by which this bacteria-derived molecule promotes bone resorption are unknown. We find that LPS induces bone marrow macrophages (BMMs) to express c-src, a protooncogene product that we demonstrate is a specific marker of commitment to the osteoclast phenotype. We next turned to possible soluble mediators of LPS-induced c-src. Of a number of osteoclastogenic cytokines tested, only TNF-alpha mirrors the c-src-enhancing effect of LPS. Suggesting that LPS augmentation of c-src is TNF-mediated, endotoxin sequentially induces BMM expression of TNF, followed by c-src. TNF and c-src expression, by cultured BMMs derived from LPS-injected mice, reflects duration of exposure to circulating endotoxin, intimating that endotoxin's effect in vivo is also mediated by TNF, Consistent with these findings, thalidomide (which antagonizes TNF action) attenuates c-src induction by LPS, An anti-TNF antibody blacks LPS enhancement of c-src mRNA, validating the cytokine's modulating role in vitro, Using BMMs of TNF receptor-deleted mice, we demonstrate that TNF induction of c-src is transmitted through the cytokine's p55, but not p75, receptor. Most importantly, LPS administered to wild-type mice prompts osteoclast precursor differentiation, manifest by profound osteoclastogenesis in marrow cultured ex vivo, and by a profusion of marrow-residing cells expressing the osteoclast marker tartrate resistant acid phosphatase, in vivo, In contrast, LPS does not substantially enhance osteoclast proliferation in mice lacking the p55TNF receptor, confirming that LPS-induced osteoclastogenesis is mediated by TNF in vivo via this receptor, Thus, therapy targeting TNF and/or its p55 receptor presents itself as a means of preventing the osteolysis of chronic bacterial infection.
引用
收藏
页码:1557 / 1565
页数:9
相关论文
共 45 条
  • [31] MICE LACKING THE TUMOR-NECROSIS-FACTOR RECEPTOR-1 ARE RESISTANT TO TNF-MEDIATED TOXICITY BUT HIGHLY SUSCEPTIBLE TO INFECTION BY LISTERIA-MONOCYTOGENES
    ROTHE, J
    LESSLAUER, W
    LOTSCHER, H
    LANG, Y
    KOEBEL, P
    KONTGEN, F
    ALTHAGE, A
    ZINKERNAGEL, R
    STEINMETZ, M
    BLUETHMANN, H
    [J]. NATURE, 1993, 364 (6440) : 798 - 802
  • [32] MONOCLONAL-ANTIBODIES SPECIFIC FOR MURINE P55 AND P75 TUMOR-NECROSIS-FACTOR RECEPTORS - IDENTIFICATION OF A NOVEL IN-VIVO ROLE FOR P75
    SHEEHAN, KCF
    PINCKARD, JK
    ARTHUR, CD
    DEHNER, LP
    GOEDDEL, DV
    SCHREIBER, RD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) : 607 - 617
  • [33] ENRICHMENT OF GENERATED MURINE OSTEOCLASTS
    SHIOI, A
    ROSS, FP
    TEITELBAUM, SL
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1994, 55 (05) : 387 - 394
  • [34] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR SUPPRESSES LIPOPOLYSACCHARIDE-INDUCED OSTEOCLAST-LIKE CELL-FORMATION IN MOUSE BONE-MARROW CULTURES
    SHUTO, T
    JIMI, E
    KUKITA, T
    HIRATA, M
    KOGA, T
    [J]. ENDOCRINOLOGY, 1994, 134 (02) : 831 - 837
  • [35] TARGETED DISRUPTION OF THE C-SRC PROTOONCOGENE LEADS TO OSTEOPETROSIS IN MICE
    SORIANO, P
    MONTGOMERY, C
    GESKE, R
    BRADLEY, A
    [J]. CELL, 1991, 64 (04) : 693 - 702
  • [36] SUDA T, 1996, BONE, V17, P87
  • [37] Endotoxin signal transduction in macrophages
    Sweet, MJ
    Hume, DA
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 60 (01) : 8 - 26
  • [38] OSTEOCLASTS EXPRESS HIGH-LEVELS OF P60C-SRC, PREFERENTIALLY ON RUFFLED BORDER MEMBRANES
    TANAKA, S
    TAKAHASHI, N
    UDAGAWA, N
    SASAKI, T
    FUKUI, Y
    KUROKAWA, T
    SUDA, T
    [J]. FEBS LETTERS, 1992, 313 (01) : 85 - 89
  • [39] 2 TNF RECEPTORS
    TARTAGLIA, LA
    GOEDDEL, DV
    [J]. IMMUNOLOGY TODAY, 1992, 13 (05): : 151 - 153
  • [40] TARTAGLIA LA, 1993, J IMMUNOL, V151, P4637